As of Feb 03, 2025, Quest Diagnostics Incorporated's Discounted Cash Flow (DCF) valuation estimates its share price at $332.6. This suggests it may be undervalued by 104.7% compared to its current price of around $162.5, using a WACC of 5.9% and growth rates of 3.0%.
As of Feb 03, 2025, Quest Diagnostics Incorporated's Weighted Average Cost of Capital (WACC) is approximately 5.9%.
As of Feb 03, 2025, Quest Diagnostics Incorporated's Enterprise Value (EV) is approximately $41.6B. This value reflects the company's total market capitalization plus debt, minus cash and cash equivalents, providing a comprehensive measure of its overall value in the market.